尿流動態装置および消耗品の世界市場（2022年～2029年）

当レポートでは、世界の尿流動態装置および消耗品市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および課題、顧客情勢、タイプ・エンドユーザー・地域別の分析、さら企業プロファイルなどを提供しています。

目次

第1章 調査手法と範囲

• 調査手法
• 調査の目的と調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

• タイプ別の市場内訳
• エンドユーザー別の市場内訳
• 地域別の市場内訳

第4章 市場力学

• 市場に影響を与える要因
  • 促進要因
  • 抑制要因
  • 市場機会
  • 影響分析

第5章 業界分析

• サプライチェーン分析
• 価格分析
• アンメットニーズ

第6章 COVID-19分析

• 市場へのCOVID-19の影響分析
  • COVID-19前の市場シナリオ
  • 現在のCOVID-19市場シナリオ
  • COVID-19後または将来のシナリオ
• COVID-19における価格変動
• 需要と供給のスペクトル
• パンデミック時の市場に関連する政府のイニシアチブ
• メーカーの戦略的イニシアチブ
• 結論

第7章 タイプ別

• イントロダクション
  • タイプ別の市場規模分析、および前年比成長分析
  • タイプ別の市場魅力指数
• 尿量測定装置
  • イントロダクション
  • 市場規模分析（2020年～2029年、および2021年～2029年）
• サイトメーター
• 携帯型尿流動態システム
• 筋電計
• ビデオ尿流動態システム
• 尿流動態消耗品
  • 尿流動態カテーテル
  • 尿流動態ポンプとトランスデューサーセット

第8章 エンドユーザー別

• イントロダクション
  • エンドユーザー別の市場規模分析、および前年比成長分析
  • エンドユーザー別の市場魅力指数
• 病院
  • イントロダクション
  • 市場規模分析（2020年～2029年、および2021年～2029年）
• クリニック
• ラボ
• その他

第9章 地域別

• イントロダクション
  • 地域別の市場規模分析（2020年～2029年、および2021年～2029年）
  • 地域別の市場魅力指数
• 北米
  • イントロダクション
  • 主要な地域固有のダイナミクス
  • タイプ別の市場規模分析、および前年比成長分析
  • エンドユーザー別の市場規模分析、および前年比成長分析
  • 国別の市場規模分析、および前年比成長分析
• 欧州
  • イントロダクション
  • 主要な地域固有のダイナミクス
  • タイプ別の市場規模分析、および前年比成長分析
  • エンドユーザー別の市場規模分析、および前年比成長分析
  • 国別の市場規模分析、および前年比成長分析
• 南米
  • イントロダクション
  • 主要な地域固有のダイナミクス
  • タイプ別の市場規模分析、および前年比成長分析
  • エンドユーザー別の市場規模分析、および前年比成長分析
  • 国別の市場規模分析、および前年比成長分析
• アジア太平洋
  • イントロダクション
  • 主要な地域固有のダイナミクス
  • タイプ別の市場規模分析、および前年比成長分析
  • エンドユーザー別の市場規模分析、および前年比成長分析
  • 国別の市場規模分析、および前年比成長分析
• 中東とアフリカ
  • イントロダクション
  • 主要な地域固有のダイナミクス
  • タイプ別の市場規模分析、および前年比成長分析
  • エンドユーザー別の市場規模分析、および前年比成長分析

第10章 競合情勢

• 主な発展と戦略
• 企業シェア分析
• 製品のベンチマーク
• 注目すべき主要企業のリスト

第11章 企業プロファイル

• Boston Scientific Corporation
  • 企業概要
  • 製品ポートフォリオ・種類
  • 主要ハイライト
  • 財務概要
• Malvern Medical Developments Ltd
• Zhejiang Chuangxiang Medical Technology Co., Ltd.
• HC Italia srl
• Ev.Service Italia srl
• Laborie Medical Technologies Corp.
• EMS Biomedical
• The Prometheus Group
• Stericom/P3 Medical
• Amecath Medical Technologies

第12章 世界の尿流動態装置および消耗品市場：DataM

• 付録
• 当社・アプリケーションについて
• お問い合わせ

Market Overview

The Global Urodynamic Equipment and Consumables Market is expected to grow at a CAGR of 6% during the forecasting period (2022-2029).

Urodynamic testing, often known as urodynamics evaluates how well the bladder and urethra do their functions of collecting and releasing urine. Urologists and urogynecologists are the most common people that perform urodynamics. It gives the doctor the information he or she needs to diagnose the reason and nature of a patient's incontinence and recommend the best treatment alternatives.

Market Dynamics

Increasing clinical trials by the market players for the urodynamic equipment is expected to drive market growth.

UroMonitor is an intravenous TAUM device that acts like a Fitbit for the bladder. It is simple to deploy and retrieve, requires no incisions or invasion of the bladder muscle, is more comfortable for patients, and provides us with a far better perspective of what happens in the patient's everyday life, allowing us to make a more accurate diagnosis. It has the potential to revolutionize urology and the identification of urinary tract problems in the lower urinary tract. Similarly, it is introduced into a patient's bladder lumen by a simple office procedure that is similar to cystoscopy or catheter placement. It collects physiological data over a four- to seven-day period and wirelessly communicates it to the patient's electronic data recorder to aid in diagnosis and clinical care by their physician. The patient can then remove the device with a string and dispose of it properly, or their urology team can remove it in the office. As a result, UroMonitor is presently undergoing preliminary clinical trials to see if it has the same or similar effects as normal urodynamic testing. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of equipment and availability of alternative treatment for urinary incontinence is expected to hamper the market growth in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The impact of the COVID-19 pandemic on urological practice in the United States, as well as insights on the health-care delivery disruptions seen in this multimodal medical specialty. While clinical visits initially increased and then fell, the frequency of surgical operations reduced significantly over the period studied, and the use of numerous diagnostic procedures remained below baseline, potentially affecting patient outcomes in the future. Moreover, the AQUA Registry and new data resources in other specialties are required to evaluate the short- and long-term repercussions of the COVID-19 pandemic on health care delivery in the United States.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.

Segment Analysis

Uroflowmetry Equipment segment is expected to hold the largest market share in urodynamic equipment and consumables market

The uroflowmetry equipment segment is expected to dominate in 2021. The segment's growth is beneficial because it allows healthcare providers to monitor the amount and length of urine flow as well as the urinary tract's functionality. Moreover, when paired with additional tests such as a cystometrogram, it can detect obstructions such as an enlarged prostate or a weak bladder. Therefore, it has increased the demand for Uroflowmetry Equipment. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global urodynamic equipment and consumables market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of urinary disorders, the rising geriatric population, and key industry players increasing their R&D activity, which has resulted in several technological breakthroughs in the region are some of the factors the market is expected to boost in the forecast period. For instance, according to the American Urological Association, Urinary incontinence affects a quarter to a third of men and women in the United States. That's millions of people in the United States. Overactive bladder (commonly known as OAB) affects about 33 million people, causing symptoms such as urgency, frequency, and urge incontinence. Moreover, Urinary incontinence is associated with aging, and men who have prostate problems are also at increased risk. Some medications are linked to urinary incontinence and some medicines make it worse.

Additionally, Laborie Medical Technologies Inc., a medical technology business, stated in June 2021 that the first Optilume treatments were done at a UK NHS Trust. Optilume is a drug-coated balloon (DCB) technology that is utilized in the treatment of benign prostatic hyperplasia (BPH) and urethral structures. It has received CE Mark clearance for use in urethral strictures. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the urodynamic equipment and consumables market are: Boston Scientific Corporation, Malvern Medical Developments Ltd, Zhejiang Chuangxiang Medical Technology Co., Ltd., HC Italia srl , Ev.Service Italia srl, Laborie Medical Technologies Corp., EMS Biomedical, The Prometheus Group, Stericom / P3 Medical and Amecath Medical Technologies.

Laborie Medical Technologies Corp.:

Overview:

Laborie is a global medical technology company specializing in Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal. The company manufactures and delivers high-quality, high-impact diagnostic and therapeutic products that help clinicians and hospitals improve patient outcomes through progressive technology and best practice.

Product Portfolio:

Nexam Pro Urodynamics System: Nexam Pro is an easy-to-use, comprehensive system that offers unique flexibility and modularity, ideal for both routine clinical urodynamics and research.

Why Purchase the Report?

• Visualize the composition of the urodynamic equipment and consumables market segmentation by type, end user and region highlighting the key commercial assets and players.

• Identify commercial opportunities in urodynamic equipment and consumables market by analyzing trends and co-development deals.

• Excel data sheet with thousands of data points of urodynamic equipment and consumables market- level 4/5 segmentation.

• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

• Product mapping in excel for the key product of all major market players

The global urodynamic equipment and consumables market report would provide an access to an approx. 45+ market data table, 40+ figures and 190 pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Type
• 3.2. Market Snippet by End user
• 3.3. Market Snippet by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing clinical trials by the market players for the urodynamic equipment is expected to drive market growth.
  • 4.1.2. Restraints:
    • 4.1.2.1. The high cost of equipment and availability of alternative treatment for urinary incontinence is expected to hamper the market growth in the forecast period.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Supply Chain Analysis
• 5.2. Pricing Analysis
• 5.3. Unmet Needs

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type Segment
• 7.2. Uroflowmetry Equipment*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Cystometry
• 7.4. Ambulatory Urodynamic Systems
• 7.5. Electromyographs
• 7.6. Video Urodynamic Systems
• 7.7. Urodynamic Consumables
  • 7.7.1. Urodynamic Catheters
  • 7.7.2. Urodynamic Pumps and Transducer Sets

8. By End user

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 8.1.2. Market Attractiveness Index, By End user Segment
• 8.2. Hospital*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Clinics
• 8.4. Laboratories
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

10. Competitive Landscape

• 10.1. Key Developments and Strategies
• 10.2. Company Share Analysis
• 10.3. Product Benchmarking
• 10.4. List of Key Companies to Watch

11. Company Profiles

• 11.1. Boston Scientific Corporation*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. Malvern Medical Developments Ltd
• 11.3. Zhejiang Chuangxiang Medical Technology Co., Ltd.
• 11.4. HC Italia srl
• 11.5. Ev.Service Italia srl
• 11.6. Laborie Medical Technologies Corp.
• 11.7. EMS Biomedical
• 11.8. The Prometheus Group
• 11.9. Stericom / P3 Medical
• 11.10. Amecath Medical Technologies

LIST NOT EXHAUSTIVE

12. Global Urodynamic Equipment and Consumables Market - DataM

• 12.1. Appendix
• 12.2. About Us and Applications
• 12.3. Contact Us